XORTX Therapeutics (XRTX) had the highest return in 2021 by a US stock in the Biotechnology Industry, returning 2,627,273.4%.
| ASSET | YEAR | % RETURN |
|---|---|---|
XORTX Therapeutics (XRTX) | 2021 | 2,627,273.42% |
MDxHealth SA ADR (MDXH) | 2021 | 865,354.55% |
Prothena (PRTA) | 2021 | 305.25% |
PDS Biotechnology (PDSB) | 2021 | 268.18% |
Sunshine Biopharma (SBFM) | 2021 | 241.69% |
Bicycle Therapeutics (BCYC) | 2021 | 238.17% |
Anavex Life Sciences (AVXL) | 2021 | 218.17% |
Kezar Life Sciences (KZR) | 2021 | 208.49% |
BioNTech SE (BNTX) | 2021 | 201.69% |
Star Equity (STRR) | 2021 | 177.25% |
Regencell Bioscience (RGC) | 2021 | 165.42% |
Indivior PLC Ordinary Shares (INDV) | 2021 | 153.68% |
Entera Bio (ENTX) | 2021 | 153.6% |
Lunai Bioworks (LNAI) | 2021 | 147.12% |
Moderna (MRNA) | 2021 | 136.86% |
Vera Therapeutics (VERA) | 2021 | 134.18% |
Annovis Bio (ANVS) | 2021 | 126.55% |
Cytokinetics (CYTK) | 2021 | 119.24% |
Celldex Therapeutics (CLDX) | 2021 | 115.14% |
Intellia Therapeutics (NTLA) | 2021 | 112.43% |
Valneva SE ADR (VALN) | 2021 | 105.06% |
Xenon Pharmaceuticals (XENE) | 2021 | 103.52% |
Catalyst Pharmaceuticals (CPRX) | 2021 | 103.3% |
Crinetics Pharmaceuticals (CRNX) | 2021 | 99.51% |
aTyr Pharma (ATYR) | 2021 | 89.59% |